Signal from the log
Adaptyv Bio
40 M$ · Series A · Switzerland
Adaptyv exploite à Lausanne des laboratoires automatisés où des agents logiciels conçoivent une expérience de biologie, la font exécuter physiquement, puis relancent une itération sur le résultat. Roche et Novo Nordisk figurent parmi les clients cités.
Verified
Announced on , logged by the watch of 27 August 2026.
- Operation
- Funding round
- Announced amount
- 40 M$
- Stage
- Series A
- Country
- Switzerland
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Highland Europe , with ACE Ventures , byFounders , Y Combinator
Provenance
Source eu-startups,pulse2,sifted
Logged on 27 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.